Apparent China Study Failure May Not Spell End For Remdesivir COVID-19 Role
Antiviral‘s Role In Severe Patients Is Bigger Question
Apparently disappointing results from the world’s first randomized study for Gilead's remdesivir in COVID-19 have some wondering about whether antiviral can still play a decisive role in some patients with COVID-19.